Ineffective Brand Promotion Causes R&D Staff Cuts In China
This article was originally published in PharmAsia News
Executive Summary
Pharmaceutical companies in China, particularly multinational ones, often cut R&D manpower when facing patent cliff with an increasing number of firms turning to more cost-effective and efficient virtual R&D and contract research organizations.